{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:56:49Z","timestamp":1778637409804,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T00:00:00Z","timestamp":1376524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Alteration of CyclinD1 was suggested to relate with development of endometrial carcinogenesis before, however CyclinD1 expression is not well defined in endometrial hyperplasia lesions. We checked the relationship between its expression and clinic-pathological variables of endometrial lesions to explore the possibility for CyclinD1 as a potential diagnostic and prognostic marker.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Cyclin D1 immunohistochemical analysis (IHC) was used to evaluate 201 fixed, paraffin-embedded endometrial samples which included simple hyperplasia (n\u2009=\u200927), atypical complex hyperplasia (ACH) (n\u2009=\u200941), endometrioid carcinoma (n\u2009=\u2009103), endometrial serous carcinoma (ESC) (n\u2009=\u200921) and clear cell carcinoma (CCC) (n\u2009=\u20099). A breast cancer with known CyclinD1 expression was selected as a positive control in each immunohistochemistry run. We also performed follow-up study to estimate patients\u2019 prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>CyclinD1 was significantly overexpressed in atypical complex hyperplasia (ACH), endometrioid carcinoma and clear cell carcinoma (CCC). The positive signaling of CyclinD1 was showed less than 40% in simple hyperplasia and endometrial serous carcinoma (ESC). The high expression of CyclinD1 was observed in metastasis carcinoma group more significantly than non-metastasis carcinoma group. Kaplan Meier analysis demonstrated that patients with high CyclinD1 expression had an obviously poor prognosis than patients without CyclinD1 staining (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Moreover, according to multivariate Cox regression analysis, CyclinD1 expression, as crucial as metastasis, was a risk marker for overall survival rate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>CyclinD1 exhibited a promising potential to predict the prognosis of patients with endometrial carcinoma. However, the statistical analysis demonstrated that CyclinD1 exhibited a poor ability to differentiate neoplastic lesions from non-neoplastic lesions; thus, the application of CyclinD1 only is not so credible for differentiation between benign and malignant lesions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Virtual slides<\/jats:title>\n            <jats:p>The virtual slides for this article can be found here: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.diagnosticpathology.diagnomx.eu\/vs\/1871063048950173\" ext-link-type=\"uri\">http:\/\/www.diagnosticpathology.diagnomx.eu\/vs\/1871063048950173<\/jats:ext-link>.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1746-1596-8-138","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T18:01:44Z","timestamp":1376589704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["CyclinD1, a prominent prognostic marker for endometrial diseases"],"prefix":"10.1186","volume":"8","author":[{"given":"Shuo","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"issue":"suppl 6","key":"819_CR1","doi-asserted-by":"crossref","first-page":"vi35","DOI":"10.1093\/annonc\/mdr374","volume":"22","author":"N Colombo","year":"2011","unstructured":"Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C, ESMO Guidelines Working Group: Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011, 22 (suppl 6): vi35-vi39.","journal-title":"Ann Oncol"},{"issue":"5","key":"819_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/ng.2583","volume":"45","author":"N Weinhold","year":"2013","unstructured":"Weinhold N, Johnson DC, Chubb D, Chen B, F\u00f6rsti A, Hosking FJ, Broderick P, Ma YP, Dobbins SE, Hose D, Walker BA, Davies FE, Kaiser MF, Li NL, Gregory WA, Jackson GH, Witzens-Harig M, Neben K, Hoffmann P, N\u00f6then MM, M\u00fchleisen TW, Eisele L, Ross FM, Jauch A, Goldschmidt H, Houlston RS, Morgan GJ, Hemminki K: The CCND1 c.870G\u2009>\u2009A polymorphism is a risk factor for t (11;14)(q13;q32) multiple myeloma. Nat Genet. 2013, 45 (5): 522-5. 10.1038\/ng.2583.","journal-title":"Nat Genet"},{"key":"819_CR3","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","volume":"84","author":"F Bosch","year":"1994","unstructured":"Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N, Tassies D, Jaffe ES, Montserrat E, Rozman C: PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood. 1994, 84: 2726-2732.","journal-title":"Blood"},{"key":"819_CR4","first-page":"86","volume":"145","author":"WI Yang","year":"1994","unstructured":"Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL: Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol. 1994, 145: 86-96.","journal-title":"Am J Pathol"},{"key":"819_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1746-1596-8-53","volume":"8","author":"W Yu","year":"2013","unstructured":"Yu W, Jin FZ, Ying YL, Gui PH: An analysis of Cyclin D1, Cytokeratin 5\/6 and Cytokeratin 8\/18 expression in breast papillomas and papillary carcinomas. Diagn Pathol. 2013, 8: 8-10.1186\/1746-1596-8-8.","journal-title":"Diagn Pathol"},{"key":"819_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00129039-200403000-00005","volume":"12","author":"A Hong","year":"2004","unstructured":"Hong A, Davies S, Stevens G, Lee CS: Cyclin D1 overexpression in AIDS-related and classic Kaposi sarcoma. Appl Immunohistochem Mol Morphol. 2004, 12: 26-30.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"819_CR7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.5858\/2006-130-792-CNECWC","volume":"130","author":"AE Horvai","year":"2006","unstructured":"Horvai AE, Kramer MJ, O\u2019Donnell R: Beta-catenin nuclear expression correlates with cyclin D1 expression in primary and metastatic synovial sarcoma: a tissue microarray study. Arch Pathol Lab Med. 2006, 130: 792-798.","journal-title":"Arch Pathol Lab Med"},{"key":"819_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/jcp.21791","volume":"220","author":"JK Kim","year":"2009","unstructured":"Kim JK, Diehl JA: Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol. 2009, 220: 292-296. 10.1002\/jcp.21791.","journal-title":"J Cell Physiol"},{"key":"819_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/modpathol.3800349","volume":"18","author":"L Lin","year":"2005","unstructured":"Lin L, Hicks D, Xu B, Sigel JE, Bergfeld WF, Montgomery E, Fisher C, Hartke M, Tubbs R, Goldblum JR: Expression profile and molecular genetic regulation of cyclin D1 expression in epithelioid sarcoma. Mod Pathol. 2005, 18: 705-709. 10.1038\/modpathol.3800349.","journal-title":"Mod Pathol"},{"key":"819_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0090-8258(89)90027-9","volume":"35","author":"FIGO","year":"1989","unstructured":"FIGO: Announcements FIGO stages-- 1988 revision. Gynecol Oncol. 1989, 35: 125-7.","journal-title":"Gynecol Oncol"},{"key":"819_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/978-1-4757-3889-6_12","volume-title":"Blaustein\u2019s Pathology of the Female Genital Tract","author":"RJ Kurman","year":"1994","unstructured":"Kurman RJ, Zaino RJ, Norris HJ: Endometrial Carcinoma. Blaustein\u2019s Pathology of the Female Genital Tract. Edited by: Kurman RJ. 1994, New York: Springer, 439-86. 4","edition":"4"},{"key":"819_CR12","first-page":"63","volume":"49","author":"GY Zhou","year":"2011","unstructured":"Zhou GY, Gao P: The derivative of molecular pathology\u2014\u2014the inevitable development track of the pathology. Journal of Shandong University (Health Sciences). 2011, 49: 63-66.","journal-title":"Journal of Shandong University (Health Sciences)"},{"key":"819_CR13","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/1097-0142(19820415)49:8<1511::AID-CNCR2820490802>3.0.CO;2-6","volume":"49","author":"WM Christopherson","year":"1982","unstructured":"Christopherson WM, Alberhasky RC, Connelly PJ: Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma. Cancer. 1982, 49: 1511-23. 10.1002\/1097-0142(19820415)49:8<1511::AID-CNCR2820490802>3.0.CO;2-6.","journal-title":"Cancer"},{"key":"819_CR14","first-page":"615","volume":"105","author":"SC Lauchlan","year":"1981","unstructured":"Lauchlan SC: Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med. 1981, 105: 615-8.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"819_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00004347-199401000-00009","volume":"13","author":"SC Lauchlan","year":"1994","unstructured":"Lauchlan SC: The secondary mullerian system revisited. Int J Gynecol Pathol. 1994, 13 (1): 73-9. 10.1097\/00004347-199401000-00009.","journal-title":"Int J Gynecol Pathol"},{"key":"819_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/350512a0","volume":"350","author":"T Motokura","year":"1991","unstructured":"Motokura T, Bloom T, Kim HG, J\u00fcppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by a bc-l 1-linked candidat e oncogene. Nature. 1991, 350: 512-10.1038\/350512a0.","journal-title":"Nature"},{"key":"819_CR17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1101\/gad.7.5.812","volume":"7","author":"V Baldin","year":"1993","unstructured":"Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993, 7: 812-21. 10.1101\/gad.7.5.812.","journal-title":"Genes Dev"},{"key":"819_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1746-1596-7-79","volume":"7","author":"G Aquino","year":"2012","unstructured":"Aquino G, Franco R, Ronconi F, Anniciello A, Russo L, De Chiara A, Panico L: Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report. Diagn Pathol. 2012, 7: 79-10.1186\/1746-1596-7-79.","journal-title":"Diagn Pathol"},{"key":"819_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/1477-3163.100401","volume":"11","author":"Y Sun","year":"2012","unstructured":"Sun Y, Luo D, Liao DJ, et al.: CyclinD1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cells. J Carcinog. 2012, 11: 12-10.4103\/1477-3163.100401.","journal-title":"J Carcinog"},{"issue":"6","key":"819_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/sj.jid.5700224","volume":"126","author":"X Mao","year":"2006","unstructured":"Mao X, Orchard G, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ: Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis. J Invest Dermatol. 2006, 126 (6): 1388-95. 10.1038\/sj.jid.5700224.","journal-title":"J Invest Dermatol"},{"key":"819_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1746-1596-6-108","volume":"6","author":"A Dekani\u0107","year":"2011","unstructured":"Dekani\u0107 A, Dintinjan RD, Budisavljevi\u0107 I, Pe\u0107ani\u0107 S, Butorac M\u017d, Jonji\u0107 N: Strong nuclear EGFR expression in colorectal carcinomas is associated with cyclin-D1 but not with gene EGFR amplification. Diagn Pathol. 2011, 6: 108-10.1186\/1746-1596-6-108.","journal-title":"Diagn Pathol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-8-138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1746-1596-8-138\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-8-138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:17:53Z","timestamp":1630545473000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/1746-1596-8-138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/1746-1596-8-138","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,15]]},"assertion":[{"value":"21 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"138"}}